141 related articles for article (PubMed ID: 3044212)
1. Adults with cyanotic congenital heart disease: hematologic management.
Perloff JK; Rosove MH; Child JS; Wright GB
Ann Intern Med; 1988 Sep; 109(5):406-13. PubMed ID: 3044212
[TBL] [Abstract][Full Text] [Related]
2. Risk of stroke in adults with cyanotic congenital heart disease.
Perloff JK; Marelli AJ; Miner PD
Circulation; 1993 Jun; 87(6):1954-9. PubMed ID: 8504509
[TBL] [Abstract][Full Text] [Related]
3. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease.
Rosove MH; Perloff JK; Hocking WG; Child JS; Canobbio MM; Skorton DJ
Lancet; 1986 Aug; 2(8502):313-5. PubMed ID: 2874330
[TBL] [Abstract][Full Text] [Related]
4. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease.
DeFilippis AP; Law K; Curtin S; Eckman JR
Cardiol Rev; 2007; 15(1):31-4. PubMed ID: 17172881
[TBL] [Abstract][Full Text] [Related]
5. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis.
Rose SS; Shah AA; Hoover DR; Saidi P
J Gen Intern Med; 2007 Dec; 22(12):1775-7. PubMed ID: 17917783
[TBL] [Abstract][Full Text] [Related]
6. Cyanotic congenital heart disease: hematologic management.
Territo MC; Rosove MH
J Am Coll Cardiol; 1991 Aug; 18(2):320-2. PubMed ID: 1856391
[No Abstract] [Full Text] [Related]
7. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
Broberg CS; Bax BE; Okonko DO; Rampling MW; Bayne S; Harries C; Davidson SJ; Uebing A; Khan AA; Thein S; Gibbs JS; Burman J; Gatzoulis MA
J Am Coll Cardiol; 2006 Jul; 48(2):356-65. PubMed ID: 16843187
[TBL] [Abstract][Full Text] [Related]
8. Management of polycythaemia in adults with cyanotic congenital heart disease.
Thorne SA
Heart; 1998 Apr; 79(4):315-6. PubMed ID: 9616333
[No Abstract] [Full Text] [Related]
9. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
Braun SL; Eicken A; Kaemmerer H
Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
[TBL] [Abstract][Full Text] [Related]
10. Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.
Blanche C; Alonso-Gonzalez R; Uribarri A; Kempny A; Swan L; Price L; Wort SJ; Beghetti M; Dimopoulos K
Int J Cardiol; 2018 Sep; 267():79-83. PubMed ID: 29807779
[TBL] [Abstract][Full Text] [Related]
11. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia.
Horigome H; Hiramatsu Y; Shigeta O; Nagasawa T; Matsui A
J Am Coll Cardiol; 2002 Mar; 39(6):1072-7. PubMed ID: 11897453
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease.
Reiss UM; Bensimhon P; Zimmerman SA; Ware RE
Am J Hematol; 2007 Aug; 82(8):740-3. PubMed ID: 17506064
[TBL] [Abstract][Full Text] [Related]
13. [The effect of lowering the hematocrit on polycythemia and thrombocytopenia in congenital cyanotic heart defect].
de Haan M; de Koning J; Ottenkamp J; Schilte PP
Tijdschr Kindergeneeskd; 1985 Oct; 53(5):178-81. PubMed ID: 2418530
[TBL] [Abstract][Full Text] [Related]
14. Hematologic Derangements among Children with Unoperated Cyanotic Congenital Heart Disease in Ethiopia.
Alemseged S; Tefera E
Ethiop J Health Sci; 2023 Nov; 33(6):955-962. PubMed ID: 38784485
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease.
Oldershaw PJ; Sutton MG
Br Heart J; 1980 Nov; 44(5):584-8. PubMed ID: 7437201
[TBL] [Abstract][Full Text] [Related]
16. Clinical update: cyanotic adult congenital heart disease.
Spence MS; Balaratnam MS; Gatzoulis MA
Lancet; 2007 Nov; 370(9598):1530-2. PubMed ID: 17980725
[No Abstract] [Full Text] [Related]
17. Hematologic effects of cardiac disease.
Maurer HM
Pediatr Clin North Am; 1972 Nov; 19(4):1083-93. PubMed ID: 4562932
[No Abstract] [Full Text] [Related]
18. Evaluation of derived Coulter red blood cell parameters for the assessment of iron deficiency in adults with congenital heart disease.
Dopsaj V; Mikovic-Golubovic G; Martinovic J; Kalimanovska-Ostric D
Int J Lab Hematol; 2012 Oct; 34(5):461-72. PubMed ID: 22452801
[TBL] [Abstract][Full Text] [Related]
19. Management of polycythaemia in adults with cyanotic congenital heart disease.
Swan L; Hillis WS
Heart; 1999 Apr; 81(4):451. PubMed ID: 10357593
[No Abstract] [Full Text] [Related]
20. Hyperuricemia in congenital heart disease.
Dearth JC; Tompkins RB; Giuliani ER; Feldt RH
Am J Dis Child; 1978 Sep; 132(9):900-2. PubMed ID: 685909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
